Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis P Garrison

Showing results (91-100 of 190) with videos related to

Pageof 19
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2024
Does Real Option Value Influence Oncologists' Treatment Recommendations? A Survey of US OncologistsMeng Li, Zizi Elsisi, William Wong, et al.
Academic Radiology|June 28, 2011
Innovation in diagnostic imaging services: assessing the potential for value-based reimbursementLouis P Garrison, Brian W Bresnahan, Mitchell K Higashi, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 24, 2017
Effects of arginine-based immunonutrition on inpatient total costs and hospitalization outcomes for patients undergoing colorectal surgerySouvik Banerjee, Louis P Garrison, Aurelie Danel, et al.
Journal of Managed Care & Specialty Pharmacy|September 26, 2017
Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription DrugsKai Yeung, Kangho Suh, Anirban Basu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 20, 2010
Preference values associated with stage III colon cancer and adjuvant chemotherapyJennie H Best, Louis P Garrison, William Hollingworth, et al.
Academic Radiology|August 10, 2014
Applying quantitative benefit-risk analysis to aid regulatory decision making in diagnostic imaging: methods, challenges, and opportunitiesMaria Agapova, Emily Beth Devine, Brian W Bresnahan, et al.
Plos One|April 8, 2015
The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United StatesBruce Wang, Joshua A Roth, Hiep Nguyen, et al.
Drug Safety|February 20, 2014
A framework for assessing the economic value of pharmacovigilance in low- and middle-income countriesJoseph B Babigumira, Andy Stergachis, Hye Lyn Choi, et al.
Health Policy (Amsterdam, Netherlands)|March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson, Sean D Sullivan, Louis P Garrison, et al.
Journal of Medical Economics|January 24, 2020
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia AKeziah Cook, Shaun P Forbes, Kelly Adamski, et al.
Pageof 19

Showing results (91-100 of 190) with videos related to

Sort By:
Pageof 19
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2024
Does Real Option Value Influence Oncologists' Treatment Recommendations? A Survey of US OncologistsMeng Li, Zizi Elsisi, William Wong, et al.
Academic Radiology|June 28, 2011
Innovation in diagnostic imaging services: assessing the potential for value-based reimbursementLouis P Garrison, Brian W Bresnahan, Mitchell K Higashi, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 24, 2017
Effects of arginine-based immunonutrition on inpatient total costs and hospitalization outcomes for patients undergoing colorectal surgerySouvik Banerjee, Louis P Garrison, Aurelie Danel, et al.
Journal of Managed Care & Specialty Pharmacy|September 26, 2017
Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription DrugsKai Yeung, Kangho Suh, Anirban Basu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 20, 2010
Preference values associated with stage III colon cancer and adjuvant chemotherapyJennie H Best, Louis P Garrison, William Hollingworth, et al.
Academic Radiology|August 10, 2014
Applying quantitative benefit-risk analysis to aid regulatory decision making in diagnostic imaging: methods, challenges, and opportunitiesMaria Agapova, Emily Beth Devine, Brian W Bresnahan, et al.
Plos One|April 8, 2015
The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United StatesBruce Wang, Joshua A Roth, Hiep Nguyen, et al.
Drug Safety|February 20, 2014
A framework for assessing the economic value of pharmacovigilance in low- and middle-income countriesJoseph B Babigumira, Andy Stergachis, Hye Lyn Choi, et al.
Health Policy (Amsterdam, Netherlands)|March 16, 2010
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturersJosh J Carlson, Sean D Sullivan, Louis P Garrison, et al.
Journal of Medical Economics|January 24, 2020
Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia AKeziah Cook, Shaun P Forbes, Kelly Adamski, et al.
Pageof 19